ESPE Abstracts

Rapidly accumulating evidence supports the role of synthetic chemicals as obesogens and cardiometabolic risks. This presentation provides an overview of the latest evidence, safe and simple steps for prevention, and business case for policy intervention....

Maternal obesity is the most common metabolic disturbance in pregnancy affecting more than 1 in 5 women in some regions. Obesity has short term risks during pregnancy for both mother and child, with increasing evidence demonstrating that there are also longer term risks of these exposures in pregnancy impacting on health of the offspring across the lifespan. Consistent and increasing evidence demonstrates a range of adverse health outcomes for offspring born to mothers who are...